Press Release Archives

Press Release

October 17, 2023

SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease

SpliceBio is eligible to receive upfront, opt-in and milestone payments up to $216 million plus…

Gerard Caelles 0

Love0

Press Release

June 20, 2023

SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program

Dr. Favre brings extensive experience in gene therapy, immunology and drug development Appointment comes at…

Gerard Caelles 0

Love0

Press Release

January 26, 2023

Splice Bio awarded with a “Colaboración Público-Privada” grant

BARCELONA, January 26, 2023 – SpliceBio, a genetic medicines company on a mission to expand…

Gerard Caelles 0

Love0

Press Release

February 16, 2022

SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline

Financing co-led by UCB Ventures and Ysios Capital with participation by New Enterprise Associates, Gilde…

Mark Viktor 0

Love0

Press Release

January 21, 2021

Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors

BARCELONA, January 21, 2021 – Splice Bio, a gene therapy company based on technology developed…

Gerard Caelles 0

Love0

Press Release

December 10, 2020

Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors

BARCELONA, December 10, 2020 – Splice Bio, a biotech company based on technology developed in…

Gerard Caelles 0

Love0

Press Release

October 20, 2020

Splice Bio awarded with a “RETOS de Colaboración” grant

BARCELONA, October 20, 2020 – Splice Bio, a biotech company based on technology developed in…

Gerard Caelles 0

Love0

Press Release

September 15, 2020

ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio

ProteoDesign rebrands as Splice Bio to develop novel gene therapies based on its proprietary intein…

Gerard Caelles 8

Love0

Press Release

SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease

SpliceBio Appoints David Favre, D.V.M., Ph.D., as Chief Development Officer to Accelerate Development of its Lead AAV Gene Therapy Program

Splice Bio awarded with a “Colaboración Público-Privada” grant

SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline

Splice Bio appoints Jean-Philippe Combal as Chairman of the Board of Directors

Splice Bio announces research funding by Cystic Fibrosis Foundation to develop novel AAV vectors

Splice Bio awarded with a “RETOS de Colaboración” grant

ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio

Recent Posts

Recent Comments

Popular Posts

Categories

Política de privacidad

www.splice.bio